SaaS Metrics
HIV Diagnostic Improvement
Human Immunodeficiency Virus (hiv)
AI Synthesis & Market Narrative
Advancements in HIV care focus on improving diagnostic turnaround times through near point-of-care monitoring and leveraging predictive analytics for mortality risk in co-infections, supported by fundamental research into host-virus interactions.
Correlated Linguistic Patterns
["near point of care HIV viral load monitoring"
"HIV-associated talaromycosis"
"multivariate predictive model"
"host\u2013virus interactions"
"turnaround time"]
Driving Media Context
Implementation bottlenecks of near point of care HIV viral load monitoring for children and young people in Tanzania: A Qualitative Study
Background Near point-of-care (n)POC Human Immunodeficiency Virus (HIV) viral load (VL) monitoring, consisting of VL testing in laboratories close to HIV tre...
Genomic landscape of the human vaginal microbiome is linked to host genetics and population of origin
Metagenomics, coupled with genome-wide association analyses, highlights population-specific patterns of variation within the vaginal microbiome and identifie...
Hippo signalling as a nexus in host–virus interactions
The Hippo signalling pathway has emerged as an important regulator of host–virus interactions, linking antiviral immunity, viral replication, inflammation, a...
Multivariate predictive model for predicting in-hospital mortality in HIV-associated talaromycosis: a multicenter retrospective study
Author summary Human immunodeficiency virus (HIV)-associated talaromycosis is a life-threatening invasive fungal infection that remains a major cause of mort...
Government health care worker training needs for intestinal schistosomiasis morbidity management
Author summary Schistosomiasis is a disease common in sub-Saharan Africa that can cause serious, lifelong health problems, even after the infection itself ha...
Structures of human telomerase with BIBR1532 reveal novel mechanism of inhibition
Telomerase, the ribonucleoprotein that maintains telomere ends, is upregulated in most cancer cells, making it a promising oncology target. Cryo-electron mic...
Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech or the Company), a global leader in cell ther...
New | phs004524.v1.p1 | Retrovirus Epidemiology Donor Study-II (REDS II) Molecular Surveillance (MS) - (REDS_II_MS_BioLINCC)
Retrovirus Epidemiology Donor Study-II (REDS II) Molecular Surveillance (MS) - (REDS_II_MS_BioLINCC) (study page
| release notes
)
Sequential chemo-immunotherapy followed by standard versus reduced thoracic radiotherapy for older and/or frail stage III non-small-cell lung cancer: A randomized open-label cohort trial
In a randomized open-label trial, Wei-Xiang Qi and colleagues investigate the feasibility of dose-reduced thoracic radiotherapy to mitigate treatment related...
7MM Human Immunodeficiency Virus (HIV) Drug Forecast and Market Analysis Report 2026: Pipeline STRs Will Not Surpass Biktarvy in Terms of Commercial Success - Outlook to 2033
The HIV market offers opportunities in unmet needs, R&D advancements, and long-acting treatments in the 7MM, focusing on innovative products and strategic pa...